ECYT

Endocyte, Inc. Common Stock
ECYT

Overview Fund Activity
Delisted

ECYT was delisted on the 20th of December, 2018.

Back to rankings

96 hedge funds and large institutions have $49.4M invested in Endocyte, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 10 closing their positions.

Holders
96
Holders Change
-1
Holders Change %
-1.03%
% of All Funds
2.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
28
Reduced
31
Closed
10
Calls
$260K
Puts
$44K
Net Calls
+$216K
Net Calls Change
+$234K

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$2.51M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$217K
3
BFA
3
BlackRock Fund Advisors
California
$5.01M
4
Stifel Financial
4
Stifel Financial
Missouri
$127K
5
BCM
5
Bridgeway Capital Management
Texas
$629K

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$3.63M
2
Millennium Management
2
Millennium Management
New York
$1.93M
3
HCMT
3
Highland Capital Management (Texas)
Texas
$932K
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$11.2M
5
Morgan Stanley
5
Morgan Stanley
New York
$244K
Name Holding Trade Value Shares
Change 		Shares
Change %
LPL Financial
101
LPL Financial
California
– -$42K -13,060 Closed
Group One Trading
102
Group One Trading
Illinois
– -$5K -1,597 Closed
Federated Hermes
103
Federated Hermes
Pennsylvania
– -$4K -1,352 Closed
1 2 3 4
5